SA
Sign upLog In

Biogen (BIIB)

Stock-Based Compensation

-$84.00M

Quarterly · Period ending: · USD

BIIB logo

BIIB Stock-Based Compensation

Latest reported-$84.00M
BIIB Quarterly Stock-Based Comp ($0.00 → -$84.00M)
High-resolution chart · PNG

BIIB stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
-84,000,000
84,000,000
59,600,000
75,300,000
74,900,000
81,000,000
75,100,000
72,700,000
70,600,000
72,800,000
54,900,000
62,200,000
73,700,000
75,600,000
67,200,000
63,600,000
55,700,000
67,600,000
58,800,000
55,700,000
54,100,000
70,000,000
49,000,000
37,700,000
44,000,000
67,700,000
38,400,000
45,900,000
52,300,000
45,700,000
38,500,000
37,300,000
38,300,000
43,400,000
30,600,000
30,100,000
34,000,000
37,000,000
37,000,000
33,700,000
38,800,000
45,300,000
29,863,000
37,800,000
41,600,000
52,100,000
56,300,000
35,652,000
37,516,000
46,340,000
31,442,000
37,464,000
30,630,000
36,757,000
30,188,000
27,911,000
28,071,000
32,396,000
26,380,000
29,226,000
24,280,000
33,119,000
33,232,000
39,224,000
44,364,000
51,006,000
41,000,000
41,010,000
41,003,000
37,889,000
41,868,000
36,692,000
33,118,000
34,529,000
31,920,000
31,790,000
29,859,000
29,560,000
24,724,000
36,434,000
42,005,000
23,620,000
18,680,000
2,916,000
8,778,000
7,851,000
16,795,000
3,797,000
4,627,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.